Genprex, Inc. Files 8-K Reporting Corporate Details
Ticker: GNPX · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1595248
Sentiment: neutral
Topics: corporate-filing, 8-K, pharmaceuticals
Related Tickers: GNPX
TL;DR
Genprex (GNPX) filed an 8-K on 6/23/25 with corporate info. Nothing major, just housekeeping.
AI Summary
Genprex, Inc. filed an 8-K on June 23, 2025, reporting other events and financial statements. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31). Genprex, Inc. is a pharmaceutical preparations company based in Austin, Texas.
Why It Matters
This filing provides essential corporate information and updates for Genprex, Inc., which is relevant for investors and stakeholders tracking the company's official disclosures.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new financial or operational information that would immediately impact the company's risk profile.
Key Numbers
- 001-38244 — SEC File Number (Identifies the company's filing with the SEC.)
- 90-0772347 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- Genprex, Inc. (company) — Registrant
- June 23, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Austin, TX (location) — Principal executive offices
- 512-537-7997 (phone_number) — Registrant's telephone number
FAQ
What is the primary business of Genprex, Inc.?
Genprex, Inc. is in the Pharmaceutical Preparations industry, with SIC code 2834.
When was this 8-K filing submitted?
This 8-K filing was submitted on June 23, 2025.
Where are Genprex, Inc.'s principal executive offices located?
The principal executive offices of Genprex, Inc. are located at 3300 Bee Cave Road, #650-227, Austin, TX 78746.
What is Genprex, Inc.'s fiscal year end?
Genprex, Inc.'s fiscal year ends on December 31.
What is the registrant's telephone number?
The registrant's telephone number is (512) 537-7997.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Genprex, Inc. (GNPX).